- Home
- LXEH vs CMND Comparison
LXEH vs CMND Comparison
Compare LXEH & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LXEH | CMND |
|---|---|---|
| Founded | 2001 | 2017 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 2.6M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LXEH | CMND |
|---|---|---|
| Price | $1.70 | $0.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.1K | ★ 276.1K |
| Earning Date | 05-01-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $0.07 |
| 52 Week High | $3.28 | $4.66 |
Technical Indicators
Market Signals| Indicator | LXEH | CMND |
|---|---|---|
| Relative Strength Index (RSI) | 55.11 | 23.19 |
| Support Level | $1.55 | $0.59 |
| Resistance Level | $2.30 | $1.27 |
| Average True Range (ATR) | 0.10 | 0.14 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 60.62 | 0.63 |
Price Performance
Historical ComparisonAbout LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is engaged in providing education services, including high school and vocational education services. It offers private basic education at the primary and junior high school levels. The Group has two reportable segments for operations, including high school and vocational education.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.